EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Reconfiguring the immune system to target cancer: Therapies based on T cells, cytokines, and vaccines

Sramona Kar, Divya Verma, Sanjana Mehrotra, Vijay Kumar Prajapati

Advances in Protein Chemistry and Structural Biology · 2025

DOI: 10.1016/bs.apcsb.2024.10.017 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advances in Protein Chemistry and Structural Biology, 2025. Verfasst von Sramona Kar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Delhi South Campus, Benito Juarez Road, Dhaula Kuan, New Delhi, India. Hauptthemen laut MEDLINE: Neoplasms, Cytokines, Cancer Vaccines, T-Lymphocytes. Die Arbeit nennt 348 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the years, extensive research has been dedicated to performing in-depth analysis of cancer to uncover the intricate details of its nature - including the types of cancer, causative agents, stimulators of disease progression, factors contributing to poor prognosis, and efficient therapies to restrict the metastatic aggressiveness. This chapter highlights the mechanisms through which different arms of the host immune system - namely cytokines, lymphocytes, antigen-presenting cells (APCs) -can be mobilized to eradicate cancer. Most malignant tumors are either poorly immunogenic, or are harbored in a highly immuno-suppressive microenvironment. This is why reinforcing the host's anti-tumor defenses, through infusion of pro-inflammatory cytokines, tumor antigen-loaded APCs, and anti-tumor cytotoxic cells has emerged as a viable treatment option against cancer. The chapter also highlights the ongoing preclinical and clinical studies in different malignancies and the outcome of various therapies. Although these methods are not foolproof, and antigen escape variants can still evade or develop resistance to customized therapies, they achieve disease stabilization in several cases when conventional treatments fail. In many instances, combination therapies involving cytokines, T cells, and vaccinations prove more effective than monotherapies. The limitations of the current therapies are also discussed, along with ongoing modifications aimed at improving efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsCytokinesCancer VaccinesT-LymphocytesImmunotherapyHumansAnimalsTumor Microenvironment

Stichwörter der Autor:innen

CAR T-cellsCancerClinical trialCytokinesImmunotherapyVaccine

Substanzen

CytokinesCancer Vaccines

Autor:innen und Institutionen

  • Department of Biochemistry, University of Delhi South Campus, Benito Juarez Road, Dhaula Kuan, New Delhi, India.
  • Department of Human Genetics, Guru Nanak Dev University, Amritsar, Punjab, India.
  • Department of Biochemistry, University of Delhi South Campus, Benito Juarez Road, Dhaula Kuan, New Delhi, India. Electronic address: vkp@south.du.ac.in.

Zitieren

APA

Kar, S., Verma, D., Mehrotra, S., & Prajapati, V. K. (2025). Reconfiguring the immune system to target cancer: Therapies based on T cells, cytokines, and vaccines. Advances in Protein Chemistry and Structural Biology. https://doi.org/10.1016/bs.apcsb.2024.10.017

Vancouver

Kar S, Verma D, Mehrotra S, Prajapati VK. Reconfiguring the immune system to target cancer: Therapies based on T cells, cytokines, and vaccines. Advances in Protein Chemistry and Structural Biology. 2025. doi:10.1016/bs.apcsb.2024.10.017

BibTeX
@article{Kar2025,
  author = {Kar, Sramona and Verma, Divya and Mehrotra, Sanjana and Prajapati, Vijay Kumar},
  title = {Reconfiguring the immune system to target cancer: Therapies based on T cells, cytokines, and vaccines},
  journal = {Advances in Protein Chemistry and Structural Biology},
  year = {2025},
  doi = {10.1016/bs.apcsb.2024.10.017}
}
Kostenlos starten →